from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2755c/hsdS.1

LFCtreatmentdescriptionclass of inhibitor

1.144

Amikacinug/mL Amikacintranslation

0.484

Cap5-10ug/mL Capreomycintranslation

0.602

Rox10-50 ug/mL Roxithromycintranslation

0.851

SM2-5 ug/mL Streptomycintranslation

1.191

Tet5-10 ug/mL Tetracyclinetranslation

0.587

Rif0.2-5ug/mL Rifampicintranscription

0.260

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.672

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.631

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.019

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.618

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.451

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.397

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.049

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.643

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.343

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.135

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.785

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.319

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.835

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.209

KCN5-20 ug/mL Potassium cyaniderespiration

0.635

NaN30.2-2 mM Sodium aziderespiration

1.416

Nigericin50 uM Nigericinrespiration

-0.601

TRC10-150 ug/mL Triclosanrespiration

-0.690

TRZ10-25 ug/mL Thioridazinerespiration

1.913

Valinomycin0.5-10 uM Valinomycinrespiration

-1.599

ZnSO42 mM ZnSO4respiration

-0.246

menadione6-10 ug/mL Menadionerespiration

0.035

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.382

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.569

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.382

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.646

NRP_1Non-replicating persistence stage 1dosRassociated

0.611

Amp0.2mg/mL AmpicillincellWall

-0.207

Cephalexin20-100 ug/mL CephalexincellWall

0.717

Cerulenin0.32-5 ug/mL CerulenincellWall

0.049

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.047

EMB10-20 ug/mL EthambutolcellWall

0.339

Eta12-40 ug/mL EthionamidecellWall

0.654

INH0.2-0.4 ug/mL IsoniazidcellWall

0.034

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.411

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.216

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.646

BZA0.12 mg/mL BenzamidearomaticAmides

0.184

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.147

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.209

H2O24 mM hydrogen peroxideDNAdamaging

-0.298

Levo10 ug/mL LevofloxacinDNAdamaging

-0.016

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.349

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.205

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.208

UVUV-irradiationDNAdamaging

-0.443

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.032

Antimycin12.5-50 ug/mL Antimycin A?

0.576

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.010

PA_110-50 ug/mL Antitubercular compound PA-1?

0.087

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.031

PA8240.2-2 ug/mL PA-824?

-1.181

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.402

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

0.454

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.205

methoxatin10-20 ug/mL Methoxatin?